Partial purification and characterization of sphingosine N-acyltransferase (ceramide synthase) from bovine liver mitochondrion-rich fraction

Lipids
H ShimenoT Kihara

Abstract

Sphingosine N-acyltransferase (ceramide synthase, E.C. 2.3.1.24) was solubilized from bovine liver mitochondrion-rich fraction with n-octyl beta-D-thioglucoside as the detergent and partially purified by sequential chromatography on columns of DE-32, shingosine affinity, and Sepharose CL-6B. The partially purified preparation migrated on SDS-polyacrylamide gel electrophoresis as two major protein bands of 62 and 72 kDa. The molecular mass of the enzyme estimated by gel filtration was 240-260 kDa, suggesting that the partially purified enzyme is present in a subunit form or simply has an aggregative nature. The specific activity of the final preparation for the condensation of sphingosine with stearoyl-CoA increased by 98.7-fold compared with the starting material. The optimal pH value for the ceramide synthesis was 7.5. The partially purified enzyme had an apparent Km of 146 microM and a Vmax of 11.1 nmol/min/mg protein for stearoyl-CoA. The Km and Vmax values toward sphingosine were 171 microM and 11.3 nmol/min/mg protein, respectively. Interestingly, sphinganine was also a good substrate for this enzyme, and the Km and Vmax values were 144 microM and 8.5 nmol/min/mg protein, respectively.

References

Jun 5, 1992·Biochimica Et Biophysica Acta·W Fürst, K Sandhoff
Mar 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J S O'Brien, Y Kishimoto
Oct 1, 1972·Archives of Biochemistry and Biophysics·M D Ullman, N S Radin
Jun 1, 1994·Archives of Biochemistry and Biophysics·N AzumaY Kishimoto
Dec 21, 1993·Biochimica Et Biophysica Acta·Y A Hannun, C M Linardic
Mar 19, 1993·Science·L M ObeidY A Hannun

❮ Previous
Next ❯

Citations

Jun 26, 2012·Cellular and Molecular Life Sciences : CMLS·Chiara Mencarelli, Pilar Martinez-Martinez
Jan 13, 2011·Histochemistry and Cell Biology·Claudia Meisslitzer-RuppitschMargit Pavelka
Sep 17, 2005·Journal of Bioenergetics and Biomembranes·Leah J Siskind
Dec 4, 2003·Journal of Theoretical Biology·Fernando Alvarez-VasquezEberhard O Voit
Jul 19, 2002·Advances in Enzyme Regulation·Helene BirbesYusuf A Hannun
May 23, 2002·Biochimie·Barbara Tomassini, Roberto Testi
Sep 15, 2001·Free Radical Biology & Medicine·N Andrieu-AbadieT Levade
Sep 22, 2000·Trends in Cell Biology·K Venkataraman, A H Futerman
Jan 18, 2003·Biochimica Et Biophysica Acta·Benjamin J PettusYusuf A Hannun
Jan 18, 2003·Biochimica Et Biophysica Acta·Nathalie Andrieu-Abadie, Thierry Levade
Jun 15, 1999·Biochimica Et Biophysica Acta·R C Dickson, R L Lester
Oct 12, 2000·The Journal of Biological Chemistry·L J Siskind, M Colombini
May 12, 2009·The Journal of Biological Chemistry·Takeshi YabuMichiaki Yamashita
Dec 15, 2010·The Journal of Biological Chemistry·Sergei A NovgorodovTatyana I Gudz
May 15, 2002·The Journal of Biological Chemistry·Leah J SiskindMarco Colombini
Apr 20, 2005·The Journal of Biological Chemistry·Jean-Philip TrumanAdriana Haimovitz-Friedman
Jan 4, 2008·The Journal of Biological Chemistry·Leah J SiskindMarco Colombini
Feb 28, 2009·Journal of Cardiovascular Pharmacology·Sergei A Novgorodov, Tatyana I Gudz
Jun 14, 2003·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Konrad Sandhoff, Thomas Kolter
Nov 3, 2011·The Journal of Clinical Investigation·Benjamin T Bikman, Scott A Summers
Oct 6, 2001·Biochemical and Biophysical Research Communications·C M MatskoA A Amoscato
Oct 6, 2010·Biochimica Et Biophysica Acta·Vincent RiouxPhilippe Legrand
Mar 3, 2009·International Journal of Radiation Oncology, Biology, Physics·Dominique ArdailClaire Rodriguez-Lafrasse
Jan 15, 2008·Free Radical Biology & Medicine·Joan VillenaAndrew F G Quest
Jun 15, 2007·Critical Reviews in Oncology/hematology·Andrea Huwiler, Uwe Zangemeister-Wittke
Aug 8, 2015·Chemistry and Physics of Lipids·Francesca CingolaniJosefina Casas
Mar 12, 2010·IUBMB Life·Michal Levy, Anthony H Futerman
Mar 20, 2010·Journal of Neurochemistry·Chiara MencarelliPilar Martínez-Martínez
Sep 26, 2006·Biochimica Et Biophysica Acta·Anthony H Futerman
Dec 13, 2006·Biochimica Et Biophysica Acta·Tarek A TahaLina M Obeid
May 24, 2006·Free Radical Biology & Medicine·Je-Seong Won, Inderjit Singh
Sep 21, 2007·Biochimica Et Biophysica Acta·Hiroshi KitagakiYusuf A Hannun
Oct 1, 2013·The Biochemical Journal·Melissa E SmithBenjamin T Bikman
Jan 18, 2012·The Biochemical Journal·Thomas D MullenLina M Obeid
Mar 1, 2015·Analytical Biochemistry·Kyle D LuttgeharmJonathan E Markham
May 9, 2012·Cell Metabolism·Jose A Chavez, Scott A Summers
Aug 13, 2013·Biochimie·Aviram Kogot-Levin, Ann Saada
Apr 1, 1999·Chemistry & Biology·J K ChenS L Schreiber
Aug 29, 2003·Biophysical Journal·Leah J SiskindMarco Colombini
Jun 20, 2006·Biophysical Journal·Matthew J ElrickMarco Colombini
Oct 20, 2006·Biochimica Et Biophysica Acta·Antonio DelgadoGemma Fabrias
Oct 26, 2016·Chemistry and Physics of Lipids·Massimo AureliSandro Sonnino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.